NCT07405151
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07405151
Title A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
Acronym MK-3475-06F
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries CHE

Facility Status City State Zip Country Details
Aichi Cancer Center ( Site 2702) RECRUITING Nagoya Aichi-ken 464-8681 Japan Details
Kanagawa Cancer Center ( Site 2701) RECRUITING Yokohama Kanagawa 241-8515 Japan Details
National Cancer Center Hospital ( Site 2700) RECRUITING Chūō Tokyo 104-0045 Japan Details
Asan Medical Center ( Site 2901) RECRUITING Seoul 05505 South Korea Details
Samsung Medical Center ( Site 2900) RECRUITING Seoul 06351 South Korea Details
Hopitaux Universitaires de Geneve HUG ( Site 3701) RECRUITING Geneva 1211 Switzerland Details
National Cheng Kung University Hospital ( Site 3001) RECRUITING Tainan 704 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field